Discover
XERS
Xeris Biopharma Holdings, Inc.
10.13
2 x 7.28
2 x 11.73
bid
ask
+
1.05
11.56%
2 @ 07:59 PM
10.10 -0.03 (0.28%)
| Ytd | 29.04% | |
| 1y | 23.54% |
9.12
day range
10.23
5.25
52 week range
11.33
| Open | 9.15 | Prev Close | 9.08 | Low | 9.12 | High | 10.23 | Mkt Cap | 1.85B |
| Vol | 4.29M | Avg Vol | 2.16M | EPS | -0.10 | P/E | N/A | Forward P/E | 25.97 |
| Beta | 0.84 | Short Ratio | 5.10 | Inst. Own | 60.12% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 8.46 | 200-d Avg | 7.20 | 1yr Est | 12.29 |
| Income Statement | |||
| Total Revenue | 92.10M | ||
| Revenues (USD) | 92.10M | ||
| Cost of Revenue | 12.51M | ||
| Gross Profit | 79.59M | ||
| Operating Expenses | 74.42M | ||
| Research and Development Expense | 10.67M | ||
| Selling, General and Administrative Expense | 61.04M | ||
| Operating Income | 5.17M | ||
| Interest Expense | 6.95M | ||
| Net Income | -31.10M | ||
| Net Income Common Stock | -31.10M | ||
| Net Income Common Stock (USD) | -31.10M | ||
| Consolidated Income | -31.10M | ||
| Earnings per Basic Share | -0.18 | ||
| Earnings per Basic Share (USD) | -0.18 | ||
| Earnings per Diluted Share | -0.18 | ||
| Earning Before Interest & Taxes (EBIT) | -24.15M | ||
| Earning Before Interest & Taxes (USD) | -24.15M | ||
| Weighted Average Shares | 172.82M | ||
| Weighted Average Shares Diluted | 172.82M | ||
| Balance Sheet | |||
| Cash and Equivalents | 121.75M | ||
| Cash and Equivalents (USD) | 121.75M | ||
| Trade and Non-Trade Receivables | 58.11M | ||
| Current Assets | 274.76M | ||
| Property, Plant & Equipment Net | 26.61M | ||
| Total Assets | 411.91M | ||
| Debt Current | 70.09M | ||
| Total Debt | 289.44M | ||
| Current Liabilities | 189.57M | ||
| Debt Non-Current | 219.35M | ||
| Total Liabilities | 421.64M | ||
| Accumulated Retained Earnings (Deficit) | -700.17M | ||
| Accumulated Other Comprehensive Income | -10.00K | ||
| Shareholders Equity | -9.73M | ||
| Shareholders Equity (USD) | -9.73M | ||
| Assets Non-Current | 137.15M | ||
| Total Debt (USD) | 289.44M | ||
| Goodwill and Intangible Assets | 105.52M | ||
| Inventory | 80.93M | ||
| Liabilities Non-Current | 232.07M | ||
| Trade and Non-Trade Payables | 9.34M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.21M | ||
| Net Cash Flow from Financing | 1.94M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 10.00M | ||
| Capital Expenditure | -209.00K | ||
| Issuance (Purchase) of Equity Shares | 1.94M | ||
| Net Cash Flow from Investing | -209.00K | ||
| Net Cash Flow from Operations | 8.26M | ||
| Share Based Compensation | 11.07M | ||